Peripheral effector‐memory CD4 + T cells reflect clinical symptom burden in pediatric allergic rhinitis
Pediatric Allergy and Immunology · 2026-10 · 37 (10)
DOI: 10.1111/pai.70509 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 15.10.2026. Verfasst von Takeshi Yamamoto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Rhinitis, Allergic, Memory T Cells. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Pediatric allergic rhinitis (AR) can substantially affect quality of life and school performance, yet conventional sensitization markers such as allergen‐specific immunoglobulin E (sIgE) do not consistently reflect symptom severity. We examined whether activation‐induced marker (AIM)‐defined allergen‐specific peripheral effector‐memory CD4 + T‐cell (peff‐mCD4) frequencies were associated with symptom burden.
Methods
In this pilot, single‐center observational study, house dust mite (HDM)‐specific responses were analyzed in 20 children and Japanese cedar pollen (JCP)‐specific responses in 19. Nasal symptom numerical rating scale (NRS) and total nasal symptom score (TNSS) were recorded. Peff‐mCD4 cells were quantified as CD154 + CD137 + cells within memory CD4 + T cells after short‐term ex vivo allergen stimulation.
Results
Peff‐mCD4 frequency was strongly associated with NRS and TNSS in both the HDM‐specific (Spearman ρ = 0.882 and 0.835, respectively) and JCP‐specific analyses ( ρ = 0.828 and 0.769, respectively; all q < 0.001). In contrast, sIgE showed weaker associations with symptom scores, and none of the four sIgE–symptom associations remained significant after FDR adjustment. These peff‐mCD4 associations remained significant after adjustment for age and sex. In exploratory ROC analyses using TNSS ≥8 as an operational threshold, peff‐mCD4 yielded AUCs of 0.867 for HDM and 0.910 for JCP.
Conclusion
Peff‐mCD4 frequency was strongly associated with symptom burden in pediatric AR. Larger longitudinal and externally validated studies are required to determine its potential utility as a peripheral blood cellular correlate of clinical symptom burden. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan.
ORCID-Profile: Takeshi Yamamoto, Eri Hayata, Kenta Zushi, Toshiyuki Kobayashi, Taiji Nakano
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Yamamoto, T., Hayata, E., Ikarashi, T., Tokitomo, H., Tanaka, K., Hiraoka, A., Zushi, K., Watanabe, K., Kobayashi, T., Nakano, T., & Hamada, H. (2026). Peripheral effector‐memory CD4 + T cells reflect clinical symptom burden in pediatric allergic rhinitis. Pediatric Allergy and Immunology, 37(10). https://doi.org/10.1111/pai.70509
Vancouver
Yamamoto T, Hayata E, Ikarashi T, Tokitomo H, Tanaka K, Hiraoka A, et al. Peripheral effector‐memory CD4 + T cells reflect clinical symptom burden in pediatric allergic rhinitis. Pediatric Allergy and Immunology. 2026;37(10). doi:10.1111/pai.70509
BibTeX
@article{Yamamoto2026,
author = {Yamamoto, Takeshi and Hayata, Eri and Ikarashi, Terumi and Tokitomo, Haruna and Tanaka, Katsuki and Hiraoka, Azusa and Zushi, Kenta and Watanabe, Kei and Kobayashi, Toshiyuki and Nakano, Taiji and Hamada, Hiromichi},
title = {Peripheral effector‐memory CD4 + T cells reflect clinical symptom burden in pediatric allergic rhinitis},
journal = {Pediatric Allergy and Immunology},
year = {2026},
volume = {37},
number = {10},
doi = {10.1111/pai.70509}
}
EUVIMED